Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
- Shima Gholizadeh
- , Emmy M. Dolman
- , Rebecca Wieriks
- , Rolf W. Sparidans
- , Wim E. Hennink
- , Robbert J. Kok
Research output: Contribution to journal › Article › peer-review
35
Citations
(Scopus)